Document is current

Any future updates will be listed below

Quantitative benefit risk analysis for prophylactic vaccines in the context of FDAs benefit risk framework

Crossref DOI link: https://doi.org/10.1038/s41541-025-01342-3

Published Online: 2026-02-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark